Adults – more in number, varied aetiologies, longer waiting lists and develop all complications including HRS
HRS in Paediatrics VERY RARE.
Hepatorenal syndrome (HRS) is defined as the occurrence of renal failure in a patient with advanced liver disease in the absence of an identifiable cause of renal failure
DIAGNOSIS OF EXCLUSION
Bilirubin interferes with assays, with hyperbilirubinaemia masking increase in SCr
Bilirubin interferes with assays, with hyperbilirubinaemia masking increase in SCr
Ethnic and Sex predilection
Liver synthetic function -production of creatinine is reduced by 50%
Muscle mass and protein malnutrition
Lower baseline range for creatinine in advanced liver disease
Delay access to timely HRS treatment and may adversely affect these patients’ prognosis.
Nitric Oxide (shear-stress-induced upregulation of endothelial NO synthase (eNOS) activity and endotoxin-mediated eNOS)
Nitric Oxide (shear-stress-induced upregulation of endothelial NO synthase (eNOS) activity and endotoxin-mediated eNOS)
Calcitonin gene-related peptide (CGRP)
Substance P
Carbon monoxide
Endocannabinoids
Overproduction of TNF-α may be a major mechanism leading to HRS
Lead to rapid deterioration of the systemic circulation and to the development of the HRS
Lead to rapid deterioration of the systemic circulation and to the development of the HRS
Gastrointestinal bleeding
Spontaneous bacterial peritonitis
Sepsis
Aggressive diuresis
Large volume Paracentesis
Cholestasis
NSAIDs
Hepatorenal syndrome (HRS) is defined as the occurrence of renal failure in a patient with advanced liver disease in the absence of an identifiable cause of renal failure
The diagnosis of HRS is one of exclusion, so investigations should be performed to rule out other common causes of AKI.
HRS and ATN difficult to differentiate
HRS and ATN difficult to differentiate
Granular casts observed in the urinary sediment in both conditions
Presence of renal tubular epithelial cells favours ATN
AKI associated with evidence of parenchymal renal disease - 73%
Determining the etiology of AKI in cirrhotic patients does not only determine the treatment plan but also foretells the prognosis.
Patients with cirrhosis and renal failure are at high risk for death while awaiting transplantation
Patients with cirrhosis and renal failure are at high risk for death while awaiting transplantation
HRS is a strong predictor of mortality
In patients listed for transplantation, the development of HRS – Untransplantable or who receive a transplant associated with increased morbidity and mortality after transplantation
Initially histological abnormalities are minimal and inconsistent
Initially histological abnormalities are minimal and inconsistent
Tubular function and sodium absorption remains intact